NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / India's 1st nasal COVID-19 vaccine by Bharat Biotech launched
    India

    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched

    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched
    Written by Prateek Talukdar
    Jan 27, 2023, 11:25 am 2 min read
    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched
    Bharat Biotech's COVID-19 intranasal vaccine iNCOVACC was launched on Thursday

    Union Health Minister Dr. Mansukh Mandaviya and Science and Technology Minister Jitendra Singh on Thursday launched Bharat Biotech's iNCOVACC, which is reportedly India's first intranasal COVID-19 vaccine. The two doses have been rolled out for people over 18 and must be taken within 28 days. It will be available at government facilities for Rs. 325 and Rs. 800 per dose in private hospitals.

    Why does this story matter?

    • The Centre approved iNCOVACC to be used as a heterologous booster around a month ago. Mandaviya informed Parliament that iNCOVACC was recommended by India's technical expert committee on immunization.
    • The nasal vaccine by Hyderabad-based Bharat Biotech received the approval of the Central Drugs Standard Control Organization (CDSCO) in September. The intranasal vaccine by the COVAXIN manufacturer could help fight vaccine hesitancy.

    Mandaviya earlier called it 'big boost' for India

    The CDSCO approved the restricted use of iNCOVACC in September for emergency situations in adults. It reportedly can't be administered to those who have already received the precautionary or booster dose. People can register for an appointment for the intranasal vaccine through the Co-WIN app or website. Mandaviya earlier termed the vaccine a "big boost" for India.

    Developed by Bharat Biotech in partnership with Washington University

    iNCOVACC or the ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine was developed by Bharat Biotech in partnership with the Washington University in St. Louis, US. The recombinant adenoviral vectored construct was designed and developed by Washington University, which also evaluated the jab's efficacy in preclinical studies. Meanwhile, the formulation, delivery device development, and human clinical trials were carried out by Bharat Biotech.

    Government funded its development in part

    The government partially funded product development and clinical trials through the Department of Biotechnology's COVID-19 Suraksha program. iNCOVACC will join the list of vaccines on Co-WIN including COVAXIN, Serum Institute of India's Covishield and Covovax, Russian Sputnik V, and Biological E Limited's Corbevax.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Vaccine
    Mansukh Mandaviya
    COVID-19
    Bharat Biotech

    Latest

    India records nearly 4,000 new COVID-19 cases—highest in 6 months     COVID-19
    F1 2023, Max Verstappen wins the Australian GP: Key stats Max Verstappen
    Should Renault bring the 2024 Espace SUV to India Renault
    Varun Dhawan issues clarification after criticism for kissing Gigi Hadid Varun Dhawan

    Vaccine

    Gurugram: Woman confined herself, son for 3 years fearing COVID-19 Gurugram
    US approves world's first vaccine for honey bees United States of America
    Delhi: Government centers run out of free COVID-19 booster vaccine Delhi
    COVID-19: India logs 227 new cases, one death India

    Mansukh Mandaviya

    Marion Biotech, linked to Uzbekistan kids' death, halts production   Ministry of Health and Family Welfare
    Mask up in crowded places: Centre advises after high-level meeting COVID-19
    Follow COVID-19 rules or suspend yatra: Health Minister to Rahul Rahul Gandhi
    Bharat Biotech's nasal COVID-19 vaccine receives drug regulator's nod Bharat Biotech

    COVID-19

    COVID-9 spike: WHO recommends additional booster shot for high-risk people World Health Organization
    UP: CM Yogi Adityanath meets Team 9 amid COVID-19 resurgence Uttar Pradesh
    India records nearly 1,900 new daily COVID-19 cases, 7 deaths Union Health Ministry
    India records nearly 1,600 daily COVID-19 cases—highest in 5 months Union Health Ministry

    Bharat Biotech

    Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs COVID-19
    COVID-19 nasal vaccines are available but should you get one?  COVID-19
    COVID-19: Centre approves Bharat Biotech's nasal vaccine as booster dose Vaccine
    Can nasal spray vaccines stop the spread of COVID-19? COVID-19

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023